Mereo BioPharma Group Plc, which focuses on oncology and rare diseases, has appointed John Lewicki as chief scientific officer, and Ann Kapoun as senior vice president of translational research and development. Both Drs Lewicki and Kapoun join Mereo from OncoMed Pharmaceuticals Inc where they were involved in the discovery and development of the cancer drug etigilimab.
Mereo BioParma announced the appointments on 30 June 2020.
Copyright 2020 Evernow Publishing Ltd
